Proteins associated with the exon junction complex also control the alternative splicing of apoptotic regulators

Molecular and Cellular Biology

Volumn 32, Issue 5, 2012, Pages 954-967

  Michelle, Laetitia ^a   Cloutier, Alexandre ^a   Toutant, Johanne ^a   Shkreta, Lulzim ^a   Thibault, Philippe ^a,b   Durand, Mathieu ^a,b   Garneau, Daniel ^a,b   Gendron, Daniel ^a,b   Lapointe, Elvy ^a,b   Couture, Sonia ^a,b   Le Hir, Hervé ^c   Klinck, Roscoe ^a,b   Elela, Sherif Abou ^a,b   Prinos, Panagiotis ^b   Chabot, Benoit ^a,b  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c PSL RESEARCH UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACINUS PROTEIN; EIF4A3 PROTEIN; EXON JUNCTION COMPLEX; GAP JUNCTION PROTEIN; MESSENGER RNA; PEPTIDES AND PROTEINS; PROTEIN BCL X; RNPS1 PROTEIN; SAP18 PROTEIN; UNCLASSIFIED DRUG; Y14 PROTEIN;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; GENE AMPLIFICATION; GENE CONTROL; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PLASMID; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ALTERNATIVE SPLICING; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-X PROTEIN; CARRIER PROTEINS; DEAD-BOX RNA HELICASES; EXONS; HEK293 CELLS; HELA CELLS; HUMANS; NUCLEAR PROTEINS; RIBONUCLEOPROTEINS; RNA INTERFERENCE; RNA, MESSENGER; RNA-BINDING PROTEINS; SPLICEOSOMES;

EID: 84857184337     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.06130-11     Document Type: Article

References (82)

1. Ashton-Beaucage D, et al. 2010. The exon junction complex controls the splicing of MAPK and other long intron-containing transcripts in Drosophila. Cell 143:251-262.
2. Bae J, Leo CP, Hsu SY, Hsueh AJ. 2000. MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain. J. Biol. Chem. 275:25255-25261.
3. Ballut L, et al. 2005. The exon junction core complex is locked onto RNA by inhibition of eIF4AIII ATPase activity. Nat. Struct. Mol. Biol. 12:861-869.
4. Blencowe BJ, Issner R, Nickerson JA, Sharp PA. 1998. A coactivator of pre-mRNA splicing. Genes Dev. 12:996-1009.
5. Boise LH, et al. 1993. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597- 608.
6. Boise LH, Thompson CB. 1997. Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc. Natl. Acad. Sci. U. S. A. 94:3759-3764.
7. Bordone L, Campbell C. 2002. DNA ligase III is degraded by calpain during cell death induced by DNA-damaging agents. J. Biol. Chem. 277: 26673-26680.
8. Boutz PL, et al. 2007. A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev. 21:1636 -1652.
9. Cardarelli L, et al. 2010. Phages have adapted the same protein fold to fulfill multiple functions in virion assembly. Proc. Natl. Acad. Sci. U. S. A. 107:14384-14389.
10. Casciola-Rosen LA, Miller DK, Anhalt GJ, Rosen A. 1994. Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J. Biol. Chem. 269:30757-30760.
11. Chalfant CE, et al. 2002. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J. Biol. Chem. 277:12587-12595.
12. Clarke MF, et al. 1995. A recombinant bcl-x s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells. Proc. Natl. Acad. Sci. U. S. A. 92:11024 -11028.
13. Cloutier P, et al. 2008. Antagonistic effects of the SRp30c protein and cryptic 5′ splice sites on the alternative splicing of the apoptotic regulator Bcl-x. J. Biol. Chem. 283:21315-21324.
14. Cory S, Huang DC, Adams JM. 2003. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22:8590-8607.
15. Das R, Reed R. 1999. Resolution of the mammalian E complex and the ATP-dependent spliceosomal complexes on native agarose mini-gels. RNA. 5:1504-1508.
16. Degen WG, Aarssen Y, Pruijn GJ, Utz PJ, van Venrooij WJ. 2000. The fate of U1 snRNP during anti-Fas induced apoptosis: specific cleavage of the U1 snRNA molecule. Cell Death Differ. 7:70-79.
17. Dignam JD. 1990. Preparation of extracts from higher eukaryotes. Methods Enzymol. 182:194-203.
18. Dominguez C, Fisette JF, Chabot B, Allain FH. 2010. Structural basis of G-tract recognition and encaging by hnRNP F quasi-RRMs. Nat. Struct. Mol. Biol. 17:853-861.
19. Du H, et al. 2010. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat. Struct. Mol. Biol. 17:187-193.
20. L promotes islet tumor cell invasion. PLoS Biol. 5:e276.
21. Fischer U, Janicke RU, Schulze-Osthoff K. 2003. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 10:76-100.
22. Fleckner J, Zhang M, Valcarcel J, Green MR. 1997. U2AF65 recruits a novel human DEAD box protein required for the U2 snRNP-branchpoint interaction. Genes Dev. 11:1864-1872.
23. Garneau D, Revil T, Fisette JF, Chabot B. 2005. Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x. J. Biol. Chem. 280:22641-22650.
24. Gehring NH, Lamprinaki S, Hentze MW, Kulozik AE. 2009. The hierarchy of exon-junction complex assembly by the spliceosome explains key features of mammalian nonsense-mediated mRNA decay. PLoS Biol. 7:e1000120.
25. Gehring NH, Lamprinaki S, Kulozik AE, Hentze MW. 2009. Disassembly of exon junction complexes by PYM. Cell 137:536-548.
26. Green DR, Kroemer G. 2004. The pathophysiology of mitochondrial cell death. Science 305:626-629.
27. Grosso AR, Martins S, Carmo-Fonseca M. 2008. The emerging role of splicing factors in cancer. EMBO Rep. 9:1087-1093.
28. Herasse M, et al. 1999. Expression and functional characteristics of calpain 3 isoforms generated through tissue-specific transcriptional and posttranscriptional events. Mol. Cell. Biol. 19:4047-4055.
29. Isken O, Maquat LE. 2008. The multiple lives of NMD factors: balancing roles in gene and genome regulation. Nat. Rev. Genet. 9:699 -712.
30. Klinck R, et al. 2008. Multiple alternative splicing markers for ovarian cancer. Cancer Res. 68:657-663.
31. Lareau LF, Inada M, Green RE, Wengrod JC, Brenner SE. 2007. Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. Nature 446:926-929.
32. Le Hir H, Izaurralde E, Maquat LE, Moore MJ. 2000. The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exonexon junctions. EMBO J. 19:6860-6869.
33. Lejeune F, Maquat LE. 2005. Mechanistic links between nonsensemediatedmRNAdecay and pre-mRNA splicing in mammalian cells. Curr. Opin. Cell Biol. 17:309-315.
34. Li CY, et al. 2004. Regulation of alternative splicing of Bcl-x by IL-6, GM-CSF and TPA. Cell Res. 14:473-479.
35. Martinez-Contreras R, et al. 2006. Intronic binding sites for hnRNP A/B and hnRNP F/H proteins stimulate pre-mRNA splicing. PLoS Biol. 4:e21.
36. Massiello A, Roesser JR, Chalfant CE. 2006. SAP155 Binds to ceramideresponsive RNA cis-element 1 and regulates the alternative 5′ splice site selection of Bcl-x pre-mRNA. FASEB J. 20:1680-1682.
37. Massiello A, et al. 2004. Identification of two RNA cis-elements that function to regulate the 5′ splice site selection of Bcl-x pre-mRNA in response to ceramide. J. Biol. Chem. 279:15799-15804.
38. Mayeda A, et al. 1999. Purification and characterization of human RNPS1: a general activator of pre-mRNA splicing. EMBO J. 18:4560-4570.
39. McGlincy NJ, Smith CW. 2008. Alternative splicing resulting in nonsense-mediated mRNA decay: what is the meaning of nonsense? Trends Biochem. Sci. 33:385-393.
40. Mendell JT, Sharifi NA, Meyers JL, Martinez-Murillo F, Dietz HC. 2004. Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise. Nat. Genet. 36:1073-1078.
41. Mercatante DR, Mohler JL, Kole R. 2002. Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents. J. Biol. Chem. 277:49374-49382.
42. Merz C, Urlaub H, Will CL, Luhrmann R. 2007. Protein composition of human mRNPs spliced in vitro and differential requirements for mRNP protein recruitment. RNA 13:116-128.
43. Michaud S, Reed R. 1991. An ATP-independent complex commits premRNA to the mammalian spliceosome assembly pathway. Genes Dev. 5:2534 -2546.
44. Moore MJ, Wang Q, Kennedy CJ, Silver PA. 2010. An alternative splicing network links cell-cycle control to apoptosis. Cell 142:625- 636.
45. Nasim FU, Hutchison S, Cordeau M, Chabot B. 2002. High-affinity hnRNP A1 binding sites and duplex-forming inverted repeats have similar effects on 5′ splice site selection in support of a common looping out and repression mechanism. RNA 8:1078 -1089.
46. Ni JZ, et al. 2007. Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsensemediated decay. Genes Dev. 21:708 -718.
47. Nilsen TW, Graveley BR. 2010. Expansion of the eukaryotic proteome by alternative splicing. Nature 463:457-463.
48. O'Connor L, et al. 1998. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17:384 -395.
49. Olopade OI, et al. 1997. Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J. Sci. Am. 3:230-237.
50. Pan Q, et al. 2006. Quantitative microarray profiling provides evidence against widespread coupling of alternative splicing with nonsensemediated mRNA decay to control gene expression. Genes Dev. 20: 153-158.
51. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. 2008. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 40:1413-1415.
52. Paradis C, et al. 2007. hnRNP I/PTB can antagonize the splicing repressor activity of SRp30c. RNA 13:1287-1300.
53. Paronetto MP, Achsel T, Massiello A, Chalfant CE, Sette C. 2007. The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x. J. Cell Biol. 176:929-939.
54. Prinos P, et al. 2011. Alternative splicing of SYK regulates mitosis and cell survival. Nat. Struct. Mol. Biol.
55. S splice isoform. J. Biol. Chem. 284:21458-21467.
56. Revil T, et al. 2007. Protein kinase C-dependent control of Bcl-x alternative splicing. Mol. Cell. Biol. 27:8431-8441.
57. Roignant JY, Treisman JE. 2010. Exon junction complex subunits are required to splice Drosophila MAP kinase, a large heterochromatic gene. Cell 143:238-250.
58. Sakashita E, Tatsumi S, Werner D, Endo H, Mayeda A. 2004. Human RNPS1 and its associated factors: a versatile alternative pre-mRNA splicing regulator in vivo. Mol. Cell. Biol. 24:1174-1187.
59. Saltzman AL, et al. 2008. Regulation of multiple core spliceosomal proteins by alternative splicing-coupled nonsense-mediated mRNA decay. Mol. Cell. Biol. 28:4320-4330.
60. Schwerk C, et al. 2003. ASAP, a novel protein complex involved in RNA processing and apoptosis. Mol. Cell. Biol. 23:2981-2990.
61. Schwerk C, Schulze-Osthoff K. 2005. Regulation of apoptosis by alternative pre-mRNA splicing. Mol. Cell 19:1-13.
62. Shen H, et al. 2008. Distinct activities of the DExD/H-box splicing factor hUAP56 facilitate stepwise assembly of the spliceosome. Genes Dev. 22: 1796-1803.
63. Shibuya T, Tange TO, Sonenberg N, Moore MJ. 2004. eIF4AIII binds splicedmRNAin the exon junction complex and is essential for nonsensemediated decay. Nat. Struct. Mol. Biol. 11:346-351.
64. Shkreta L, et al. 2008. Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes. Mol. Cancer Ther. 7:1398-1409.
65. Silver DL, et al. 2010. The exon junction complex component Magoh controls brain size by regulating neural stem cell division. Nat. Neurosci. 13:551-558.
66. Simard MJ, Chabot B. 2002. SRp30c is a repressor of 3′ splice site utilization. Mol. Cell. Biol. 22:4001-4010.
67. Singh KK, et al. 2010. Human SAP18 mediates assembly of a splicing regulatory multiprotein complex via its ubiquitin-like fold.RNA16:2442-2454.
68. Stamm S, et al. 2005. Function of alternative splicing. Gene 344:1-20.
69. Sudo H, et al. 2010. Knockdown of COPA, identified by loss-of-function screen, induces apoptosis and suppresses tumor growth in mesothelioma mouse model. Genomics 95:210-216.
70. Tange TO, Shibuya T, Jurica MS, Moore MJ. 2005. Biochemical analysis of the EJC reveals two new factors and a stable tetrameric protein core. RNA 11:1869-1883.
71. Tao W, et al. 2005. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. Cancer Cell 8:49 -59.
72. Tawfic S, et al. 2001. Protein kinase CK2 signal in neoplasia. Histol. Histopathol. 16:573-582.
73. Trembley JH, et al. 2005. Activation of pre-mRNA splicing by human RNPS1 is regulated by CK2 phosphorylation. Mol. Cell. Biol. 25:1446-1457.
74. Veitia RA, Bottani S, Birchler JA. 2008. Cellular reactions to gene dosage imbalance: genomic, transcriptomic and proteomic effects. Trends Genet. 24:390-397.
75. Venables JP, et al. 2008. Identification of alternative splicing markers for breast cancer. Cancer Res. 68:9525-9531.
76. Venables JP, et al. 2009. Cancer-associated regulation of alternative splicing. Nat. Struct. Mol. Biol. 16:670-676.
77. Venables JP, et al. 2008. Multiple and specific mRNA processing targets for the major human hnRNP proteins. Mol. Cell. Biol. 28:6033- 6043.
78. Wang ET, et al. 2008. Alternative isoform regulation in human tissue transcriptomes. Nature 456:470-476.
79. Wollerton MC, Gooding C, Wagner EJ, Garcia-Blanco MA, Smith CW. 2004. Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay. Mol. Cell 13:91-100.
80. Yamane K, Kinsella TJ. 2005. Casein kinase 2 regulates both apoptosis and the cell cycle following DNA damage induced by 6-thioguanine. Clin. Cancer Res. 11:2355-2363.
81. Youle RJ, Strasser A. 2008. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9:47-59.
82. Zhou Z, et al. 2000. The protein Aly links pre-messenger-RNA splicing to nuclear export in metazoans. Nature 407:401- 405.